Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 1
1949 2
1950 1
1951 2
1952 1
1954 2
1955 3
1956 4
1958 1
1959 5
1960 4
1961 6
1962 1
1964 2
1965 1
1966 5
1967 1
1968 2
1969 3
1970 5
1971 3
1972 3
1973 8
1974 1
1975 4
1976 3
1977 5
1978 4
1979 6
1980 2
1982 3
1983 6
1984 6
1985 9
1986 7
1987 6
1988 9
1989 12
1990 9
1991 8
1992 12
1993 9
1994 8
1995 15
1996 13
1997 15
1998 11
1999 11
2000 11
2001 5
2002 9
2003 16
2004 18
2005 14
2006 23
2007 22
2008 32
2009 50
2010 37
2011 26
2012 36
2013 44
2014 28
2015 36
2016 45
2017 46
2018 41
2019 33
2020 47
2021 31
2022 48
2023 47
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

919 results

Results by year

Filters applied: . Clear all
Page 1
In vivo tumor growth of high-grade serous ovarian cancer cell lines.
Mitra AK, Davis DA, Tomar S, Roy L, Gurler H, Xie J, Lantvit DD, Cardenas H, Fang F, Liu Y, Loughran E, Yang J, Sharon Stack M, Emerson RE, Cowden Dahl KD, V Barbolina M, Nephew KP, Matei D, Burdette JE. Mitra AK, et al. Among authors: roy l. Gynecol Oncol. 2015 Aug;138(2):372-7. doi: 10.1016/j.ygyno.2015.05.040. Epub 2015 Jun 5. Gynecol Oncol. 2015. PMID: 26050922 Free PMC article.
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.
Emanuel RM, Dueck AC, Geyer HL, Kiladjian JJ, Slot S, Zweegman S, te Boekhorst PA, Commandeur S, Schouten HC, Sackmann F, Kerguelen Fuentes A, Hernández-Maraver D, Pahl HL, Griesshammer M, Stegelmann F, Doehner K, Lehmann T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto JC, Ranta D, Roy L, Cahn JY, Harrison CN, Radia D, Muxi P, Maldonado N, Besses C, Cervantes F, Johansson PL, Barbui T, Barosi G, Vannucchi AM, Passamonti F, Andreasson B, Ferrari ML, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Mesa RA. Emanuel RM, et al. Among authors: roy l. J Clin Oncol. 2012 Nov 20;30(33):4098-103. doi: 10.1200/JCO.2012.42.3863. Epub 2012 Oct 15. J Clin Oncol. 2012. PMID: 23071245 Free PMC article.
Immune response and possible therapeutics in COVID-19.
Dutta A, Roy A, Roy L, Chattopadhyay S, Chatterjee S. Dutta A, et al. Among authors: roy l. RSC Adv. 2021 Jan 4;11(2):960-977. doi: 10.1039/d0ra08901j. eCollection 2020 Dec 24. RSC Adv. 2021. PMID: 35423713 Free PMC article. Review.
Peptide therapeutics in the management of metastatic cancers.
Bose D, Roy L, Chatterjee S. Bose D, et al. Among authors: roy l. RSC Adv. 2022 Aug 2;12(33):21353-21373. doi: 10.1039/d2ra02062a. eCollection 2022 Jul 21. RSC Adv. 2022. PMID: 35975072 Free PMC article. Review.
Targeting Ca2+ signaling: A new arsenal against cancer.
Panda S, Chatterjee O, Roy L, Chatterjee S. Panda S, et al. Among authors: roy l. Drug Discov Today. 2022 Mar;27(3):923-934. doi: 10.1016/j.drudis.2021.11.012. Epub 2021 Nov 15. Drug Discov Today. 2022. PMID: 34793973 Review.
Radiation dose rate effects: what is new and what is needed?
Lowe D, Roy L, Tabocchini MA, Rühm W, Wakeford R, Woloschak GE, Laurier D. Lowe D, et al. Among authors: roy l. Radiat Environ Biophys. 2022 Nov;61(4):507-543. doi: 10.1007/s00411-022-00996-0. Epub 2022 Oct 15. Radiat Environ Biophys. 2022. PMID: 36241855 Free PMC article. Review.
AsthmaMap: An interactive knowledge repository for mechanisms of asthma.
Mazein A, Ivanova O, Balaur I, Ostaszewski M, Berzhitskaya V, Serebriyskaya T, Ligon T, Hasenauer J, De Meulder B, Overall RW, Roy L, Knowles RG, Wheelock CE, Dahlen SE, Chung KF, Adcock IM, Roberts G, Djukanovic R, Pellet J, Gawron P, Balling R, Maitland-van der Zee AH, Schneider R, Sterk PJ, Auffray C; U-BIOPRED Study Group,; eTRIKS Consortium. Mazein A, et al. Among authors: roy l. J Allergy Clin Immunol. 2021 Mar;147(3):853-856. doi: 10.1016/j.jaci.2020.11.032. Epub 2020 Dec 9. J Allergy Clin Immunol. 2021. PMID: 33309742 No abstract available.
GraphML-SBGN bidirectional converter for metabolic networks.
Balaur I, Roy L, Touré V, Mazein A, Auffray C. Balaur I, et al. Among authors: roy l. J Integr Bioinform. 2022 Dec 26;19(4):20220030. doi: 10.1515/jib-2022-0030. eCollection 2022 Dec 1. J Integr Bioinform. 2022. PMID: 36563404 Free PMC article.
Pharmaceutical cocrystals and poorly soluble drugs.
Thakuria R, Delori A, Jones W, Lipert MP, Roy L, Rodríguez-Hornedo N. Thakuria R, et al. Among authors: roy l. Int J Pharm. 2013 Aug 30;453(1):101-25. doi: 10.1016/j.ijpharm.2012.10.043. Epub 2012 Dec 1. Int J Pharm. 2013. PMID: 23207015 Review.
919 results